Netarsudil

Basic Information

Item Value
DrugBank ID DB13931
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 60

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 primary hereditary glaucoma KG + DL
2 glaucoma KG + DL
3 hypoglycemia KG + DL
4 Axenfeld anomaly KG + DL
5 glaucoma 1, open angle KG + DL
6 open angle glaucoma KG + DL
7 hydrophthalmos KG + DL
8 hereditary thrombocytopenia with normal platelets KG + DL
9 dense granule disease KG + DL
10 marcothrombocytopenia with mitral valve insufficiency KG + DL
11 transient neonatal thrombocytopenia KG + DL
12 lingual-facial-buccal dyskinesia KG + DL
13 thrombocytopenia KG + DL
14 visceral calciphylaxis KG + DL
15 chronic tic disorder KG + DL
16 benign shuddering attacks KG + DL
17 extrapyramidal and movement disease KG + DL
18 psychogenic movement disorders KG + DL
19 benign paroxysmal tonic upgaze of childhood with ataxia KG + DL
20 primary orthostatic tremor KG + DL
21 tremor-nystagmus-duodenal ulcer syndrome KG + DL
22 tinea nigra KG + DL
23 venous thoracic outlet syndrome KG + DL
24 arterial thoracic outlet syndrome KG + DL
25 atheroembolism of kidney KG + DL
26 non-syndromic esophageal malformation KG + DL
27 angiodysplasia of stomach KG + DL
28 hemangioendothelioma KG + DL
29 blue toe syndrome KG + DL
30 idiopathic spontaneous coronary artery dissection KG + DL
31 respiratory failure KG + DL
32 neurogenic thoracic outlet syndrome KG + DL
33 congenital glaucoma KG + DL
34 lymphangiectasis KG + DL
35 Alzheimer disease without neurofibrillary tangles KG + DL
36 arterial dissection-lentiginosis syndrome KG + DL
37 vascular disease KG + DL
38 oral candidiasis KG + DL
39 esophageal disease KG + DL
40 osteoradionecrosis of the mandible KG + DL
41 commissural lip fistula KG + DL
42 burning mouth syndrome KG + DL
43 oral leukoedema KG + DL
44 dermatophytosis KG + DL
45 overactive bladder (disease) KG + DL
46 xerophthalmia KG + DL
47 biotin metabolic disease KG + DL
48 progeria-short stature-pigmented nevi syndrome KG + DL
49 diaphragm disease KG + DL
50 acquired lactic acidosis KG + DL

(Showing top 50 of 60 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.